Conclusion
SECONDARY
This Bayesian statistical analysis plan for the SafeBoosC-III trial includes a detailed predefined description of how data will be analysed and presented for our secondary analyses. We have included detailed descriptions of the statistical considerations aimed to limit selective reporting bias. This statistical analysis plan will likely increase the validity of our results.